News

Scientists from Uppsala University describe how they have been able to predict how drug molecules that can be used against cancer bind to G-protein-coupled receptors.

According to new research, patients undergoing active cancer treatment who develop COVID-19 don’t fare any worse than other hospitalized patients.

For the first time, researchers from the Moscow Institute of Physics and Technology and their colleagues have succeeded in using RNA sequencing as an alternative to immunohistochemistry for cancer diagnostics.

New research has revealed novel insights into the molecular circuitry controlling the growth and spread of cancer. The researchers have uncovered new pathways involved in these key processes of cancer progression that may hold potential as therapeutic targets.

A new precision drug targeting cancer’s ability to repair its DNA has shown promising results in a clinical trial. The study, designed to test the drug’s safety, found that half of the participants given the new drug either alone or with platinum chemotherapy saw their cancer stop growing, and two participants saw their tumors shrink or disappear completely.

A major Phase 3 trial of capivasertib, a cancer drug has begun. The trial will enrol ~830 patients across 20 countries and will examine the effects of the drug in premenopausal or postmenopausal women, and men, with an advanced form of oestrogen receptor-positive, human epidermal growth factor receptor 2 negative breast cancer.

An innovative use of focused ultrasound is showing promise against glioblastoma and could prove useful against other difficult-to-treat cancers.

Scientists seeking to understand the mechanism of a DNA-repairing protein have discovered that the molecule performs its functions by first marking and then further breaking damaged DNA.

New research, conducted by a team from the University of California San Diego School of Medicine, indicates that the manipulation of macrophages, could be a viable treatment strategy for cancer.

A new program named PATRIOT, is using organoids to provide a whole new level of accuracy in prescribing anti-cancer treatments to patients.